Abby Paine
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Long-term efficacy of biologics in moderate-to-severe hidradenitis suppurativa: A systematic review and MAIC.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: October 02, 2025
Loncastuximab Tesirine Versus Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory DLBCL After ≥ 2 Lines of Therapy: Matching-Adjusted Indirect Comparison.
Journal: Advances in therapy
Published: October 29, 2024
Network Meta-analysis of Randomized Controlled Trials in Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer: Comparisons Involving Ramucirumab.
Journal: Journal of gastrointestinal cancer
Published: September 29, 2024
An Indirect Treatment Comparison of Lenvatinib for the First-Line Treatment of Patients with Unresectable Hepatocellular Carcinoma.
Journal: Advances in therapy
Published: September 19, 2024
Efficacy and Safety of Brolucizumab, Aflibercept, and Ranibizumab for the Treatment of Patients with Visual Impairment Due to Diabetic Macular Oedema: A Systematic Review and Network Meta-Analysis.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: March 24, 2023
Prognostic models for clinical outcomes in patients with venous leg ulcers: A systematic review.
Journal: Journal of vascular surgery. Venous and lymphatic disorders
Published: February 28, 2023
Methods for Estimating Long-Term Outcomes for Trastuzumab Deruxtecan in HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies.
Journal: Targeted oncology
Published: October 05, 2022
An indirect treatment comparison of the efficacy of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg.
Journal: Diabetes, obesity & metabolism
Published: April 30, 2021
A population-adjusted indirect comparison of cardiovascular benefits of once-weekly subcutaneous semaglutide and dulaglutide in the treatment of patients with type 2 diabetes, with or without established cardiovascular disease.
Journal: Endocrinology, diabetes & metabolism
Published: February 25, 2021
Efficacy of Once-Weekly Semaglutide vs Empagliflozin Added to Metformin in Type 2 Diabetes: Patient-Level Meta-analysis.
Journal: The Journal of clinical endocrinology and metabolism
Published: June 29, 2020
Orally Administered Semaglutide Versus GLP-1 RAs in Patients with Type 2 Diabetes Previously Receiving 1-2 Oral Antidiabetics: Systematic Review and Network Meta-Analysis.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: August 30, 2019
First-line treatment in the management of advanced renal cell carcinoma: systematic review and network meta-analysis.
Journal: Expert opinion on pharmacotherapy
Published: July 22, 2015
Last Updated: 09/26/2026